US 7488805
Apoptosis proteins
granted A61KA61K38/00A61P
Quick answer
US patent 7488805 (Apoptosis proteins) held by Rigel Pharmaceuticals, Inc. expires Mon Feb 05 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Rigel Pharmaceuticals, Inc.
- Grant date
- Tue Feb 10 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 05 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 3
- CPC classes
- A61K, A61K38/00, A61P, A61P43/00